Guardant Wins $292.5M Verdict Against Natera | United Pays More To Its Own Doctors | Future: Personalized Care & AI
Praveen Suthrum
Cofounder, NextServices | Author, The Shift, Scope Forward | GI Mastermind
Buy The Shift on your local Amazon here: https://geni.us/TheShiftBySuthrum.
Gastroenterology is on the brink of a revolution, as highlighted by Neil D. Parikh, MD, chair of the GI Alliance Innovation Committee.
Guardant Health has achieved a historic legal victory, securing $292.5 million, including $175.5 million in punitive damages, after a U.S. District Court jury found Natera guilty of false advertising and unfair competition.
GLP-1 receptor agonists show promise for weight loss, but their effectiveness varies by patient phenotype, with potential risks requiring precision medicine approaches and lifestyle integration for optimal results.
A STAT investigation, in collaboration with Tribunus Health, reveals that UnitedHealth Group pays its own Optum-branded physician practices significantly more than it pays independent doctors for similar services in the same markets.
3 gastroenterology physicians face lawsuits in 1 week (Becker's GI & Endoscopy)
Becker's reported on three gastroenterologists or GI surgeons who faced lawsuits in one week.?
Dr. Aja McCutchen shares her insights on negotiating and balancing the interplay between entrepreneurship and early career medical practice.
This article aims to clarify the group practice requirement component of the Stark Law, helping physicians better understand and comply with its conditions.
领英推荐
Capitalizing On The GI M&A Market, With Sap Sinha (Podcast) (The Corner Series)
At fast-growing Allied Digestive Health, with 194 GI physicians, 75 nurse practitioners, and locations in New Jersey and New York, COO Sap Sinha is excited about the future.
Barricade Therapeutics Secures $14 Million CPRIT Grant to Advance Colorectal Cancer Treatment (Citybiz)
Barricade Therapeutics has received a $14M grant from the Cancer Prevention and Research Institute of Texas (CPRIT) to support Phase 1 clinical trials.
IBS-C Diagnostic Criteria and Tools: What Providers Need to Know (Gastro Girl Podcast)
Dr. Kyle Staller, a gastroenterologist and neurogastroenterologist at Mass General, unpacks the complexities of IBS-C diagnosis, addressing common misconceptions and highlighting the crucial role of the brain-gut connection.
Interim results from the phase 3 ESSENCE trial reveal that semaglutide is effective in treating metabolic dysfunction–associated steatohepatitis (MASH) in patients with moderate to advanced liver fibrosis.
Medtronic has secured a three-year IDIQ contract with the U.S. Department of Veterans Affairs (VA) to install nearly 100 additional GI Genius? AI-powered endoscopy units across VA medical centers nationwide.
NTT Corporation and Olympus Corporation have successfully demonstrated a groundbreaking cloud endoscopy system using NTT's IOWN APN technology.
Gut Check: New Study Challenges Gastroparesis Diagnostics (GI & Endoscopy News)
Research presented at the 2024 American Foregut Society meeting challenges traditional methods of diagnosing gastroparesis.
For weekly gastroenterology business/tech updates directly in your inbox, subscribe to the Scope Forward newsletter.